Zelle Biotechnology Pvt Ltd: Offering State-Of-The-Art Technologies For Biopharma & Life Sciences Industry

Anurag Tulsyan

Managing Director

Anurag Tulsyan

Managing Director

As one of the first countries to have a dedicated department for biotechnology, the market for Indian biotechnology companies has been significantly propelling forward. This is backed by the setting up of BIR AC to strengthen and empower emerging Biotechnology enterprises in undertaking strategic research and innovation.

The growth is also driven by the recent policies initiated by the Government of India such as Make in India, Startup India, among others for boosting entrepreneurial development, human resource development and innovative research. However, biotechnology companies are expected to deliver cost-effective products and services with a quick turnaround time to deliver without compromising on quality aspects.

This is where Zelle Biotechnology Pvt. Ltd., founded in October 2004 has been exceeding its customers’ expectations by offering best-in-class products, technologies and services for the players in Indian Biotech and Life Sciences industry. With its strong scientific focus and client driven attitude, Zelle has established itself as one of the most valuable partners within the industry today. They are a DSIR recognized and GLP

compliant laboratory having extensive and varied experience in Upstream and Downstream Development, Analytical Method Development, Bioassays, and Method Transfers.

Bringing forth Creativity, Scientific vigilance, and Customer-oriented approach
“With over 5000 sq. ft. dedicated to our fully equipped analytical and process development laboratory at a prime location in Mumbai, we deliver significant value to our customers by leveraging our scientific skills and almost two decades of experience, that has helped us to get a pulse of the biotechnology industry and markets in India. The unparalleled creativity, scientific vigilance, and customer-oriented approach give us an edge over our competition in the market. This is further ensured through the 50 man-years of experience and expertise of Zelle's technically adept team and, our prestigious association with more than 12 leading global companies in the Bio-Pharma & Life Sciences spectrum that speaks for itself,” says Anurag Tulsyan, Managing Director at Zelle Biotechnology Pvt. Ltd.

Zelle’s products and outsourced services portfolio encompasses Host Cell Protein, Host Cell DNA detection products, mycoplasma detection, cell culture media and Molecular Biology Reagents among others. And to top it off, they also outsource cell line development for biosimilars, biological and physico-chemical testing services. “Our vision is to consolidate Zelle Biotechnology as a leading firm for marketing of products & services to the Life Sciences and Biopharma industry in India and to make it a preferred choice amongst the industry,” states Anurag.

On the Path of Becoming a Global CRO
Over the years, their team has worked on a variety of therapeutics like monoclonal antibodies, anti-clotting factors, insulin analogs, fusion proteins and immune modulators. The data generated by the laboratory has been used in submissions to the USFDA, RCGM (India), TGA (Australia) and PEI – Paul Ehrlich Institute (Germany). Good documentation practices, fully compliant software and IT systems utilization to run the laboratory gives them the needed credibility in conducting research at the facility. With a GLP certification in the pipeline, Zelle Lab is on track to become a global CRO.

Furthermore, this is backed by its laboratory which is equipped with state of the art analytical equipment like the QTOF, CD, DSC and multi-mode plate readers. “The team regularly conducts bio similarity studies in post translational modifications, secondary and tertiary structure as well as thermal stability. With expandable capacity of 50,000 sq. ft. and more, the Zelle Lab is a fully equipped Analytical and Process Development Laboratory. It is our endeavor to deliver significant value to ourcustomers by leveraging our scientific skills,” concludes Anurag.